iShares Core MSCI World ex Australia ESG (AUD Hedged) ETF (IHWL)

Overview

Rhythm Biosciences Limited is a pioneering medical diagnostics company based in Australia, focused on the development and provision of innovative blood test solutions for cancer detection. Founded in the year 2017, the company has established its headquarters in Parkville, Australia. It aims to improve early cancer detection rates, thereby potentially saving lives and reducing healthcare costs through the early diagnosis of cancer. Rhythm Biosciences is committed to research and development in the diagnostic field, particularly in identifying biomarkers that could lead to the early detection of various cancers.

Products and Services

The company specializes in developing diagnostic tests that offer a non-invasive, cost-effective, and efficient way for the early detection of cancer. The main product under its portfolio includes:

• ColoSTAT: This is a proprietary blood test designed for the early detection of colorectal cancer, the development of which showcases Rhythm Biosciences' dedication to combating one of the most common cancers globally. The ColoSTAT blood test aims to provide a more accessible and patient-friendly alternative to current screening methods like colonoscopies, which are more invasive, costly, and less likely to be undertaken by the general population. By focusing on colorectal cancer, Rhythm Biosciences addresses a critical need for early detection and intervention, potentially leading to better patient outcomes and survival rates.